These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9674761)

  • 1. Pharmacologic treatment of cognition in Alzheimer's dementia.
    Farlow MR; Evans RM
    Neurology; 1998 Jul; 51(1 Suppl 1):S36-44; discussion S65-7. PubMed ID: 9674761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.
    Grundman M; Corey-Bloom J; Thal LJ
    J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
    J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors as Alzheimer's therapeutics (Review).
    Sharma K
    Mol Med Rep; 2019 Aug; 20(2):1479-1487. PubMed ID: 31257471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs influencing cognitive function.
    Kuruvilla A; Devi V
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):241-51. PubMed ID: 7883287
    [No Abstract]   [Full Text] [Related]  

  • 6. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.
    van Reekum R; Simard M; Farcnik K
    Can Fam Physician; 1999 Apr; 45():945-52. PubMed ID: 10216793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
    Lemière J; Van Gool D; Dom R
    Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Kamkwalala AR; Newhouse PA
    Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil in the treatment of patients with Alzheimer's disease.
    Tsuno N
    Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of Alzheimer's disease].
    Johannsen P
    Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging treatments in dementia.
    Scheltens P; van Gool WA
    Eur Neurol; 1997; 38(3):184-9. PubMed ID: 9363830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
    J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic approaches to Alzheimer's disease.
    Schneider LS
    J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.